The store will not work correctly when cookies are disabled.
5-(2,3-dihydroxybenzylidene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione
ID: ALA5287271
Max Phase: Preclinical
Molecular Formula: C13H12N2O5
Molecular Weight: 276.25
Associated Items:
Names and Identifiers
Canonical SMILES: CN1C(=O)C(=Cc2cccc(O)c2O)C(=O)N(C)C1=O
Standard InChI: InChI=1S/C13H12N2O5/c1-14-11(18)8(12(19)15(2)13(14)20)6-7-4-3-5-9(16)10(7)17/h3-6,16-17H,1-2H3
Standard InChI Key: KBWSPGNYBUVVOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
0.3587 -0.8257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0733 -0.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7851 -0.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7851 -1.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0751 -2.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3587 -1.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3559 -0.4132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3559 0.4120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0705 0.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0705 1.6497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3558 2.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3587 1.6498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3587 0.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 2.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0733 2.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3558 2.8875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7851 0.4120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0733 0.4120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0751 -2.8875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3559 -2.0668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
1 7 1 0
7 8 2 0
9 8 1 0
10 9 1 0
11 10 1 0
12 11 1 0
13 12 1 0
8 13 1 0
10 14 1 0
12 15 1 0
11 16 2 0
9 17 2 0
13 18 2 0
5 19 1 0
6 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.25 | Molecular Weight (Monoisotopic): 276.0746 | AlogP: 0.53 | #Rotatable Bonds: 1 |
Polar Surface Area: 98.15 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.07 | CX Basic pKa: ┄ | CX LogP: 0.62 | CX LogD: 0.61 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.44 | Np Likeness Score: -0.51 |
References
1. Shi YY, Wei B, Zhou J, Yin ZL, Zhao F, Peng YJ, Yu QW, Wang XL, Chen YJ.. (2022) Discovery of 5-(3,4-dihydroxybenzylidene)-1,3-dimethylpyrimidine- 2,4,6(1H,3H,5H)-trione as a novel and effective cardioprotective agent via dual anti-inflammatory and anti-oxidative activities., 244 [PMID:36274277] [10.1016/j.ejmech.2022.114848] |